Find Academic Supervisors

Yuval SilbermanView profile

Associate Professor

• Alcohol Use Disorder
• Neuroscience
• Neurobiology
• +3 more

Yuval Silberman is an Associate Professor in the Department of Neuroscience and Experimental Therapeutics at Penn State College of Medicine, serving concurrently as Associate Dean for Interdisciplinary Research. His work focuses on neurobiological mechanisms underlying alcohol use disorder, neuroimmune interactions, and neuropharmacology. Research interests include ethanol's effects on brain circuits, norepinephrine modulation, corticotropin-releasing hormone pathways, and the basolateral amygdala's role in addiction. Recent studies investigate cannabidiol's impact on withdrawal symptoms and insulin's potential in treating alcohol dependence. He leads NIH-funded projects exploring vagal-hypothalamic alcohol modulation (2024-2025), diet-alcohol cross-sensitization (2019-2024), and noradrenergic/CRF circuit interactions (2016-2020). Collaborations involve neuroimmunology (e.g., angiotensin research) and translational medicine through the Center for Cannabis and Natural Product Pharmaceuticals. Recipient of 2023 Dean's Award for Excellence in Teaching 2020 Samuel Hinkle Junior Faculty Research Award winner Active in grant acquisition with total of 6 funded projects since 2007, totaling over $9M in NIH awards. Supervises interdisciplinary research teams integrating molecular neuroscience, behavioral analysis, and clinical trial methodologies.

• Hallucinations
• Schizophrenia Spectrum Disorders
• First-Episode Psychosis
• +4 more

Dr. Sanne Brederoo is a researcher at the University Medical Center Groningen's Department of Psychiatry, specializing in hallucination phenomenology, schizophrenia spectrum disorders, and antipsychotic medication effects. Key research areas: Hallucinations, First-Episode Psychosis, Religiosity-Psychosis Interactions Active contributor to HAMLETT OPHELIA Consortium and international antipsychotic dose reduction studies Her recent publications analyze: Hallucination clustering across sensory modalities Relationship between felt presence and hallucination proneness D2 receptor affinity in antipsychotic tapering Cross-cultural color-emotion associations Religiosity's impact on hallucination phenomenology Media contributions include expert commentary on psychosis and hallucination research through Dutch public platforms.

Anel JaramilloView profile

Assistant Professor

• Alcohol abuse
• Anxiety
• Stress
• +3 more

Anel Jaramillo is an Assistant Professor in the Department of Pharmaceutical Sciences at the University of Kentucky, where she investigates neurobiological mechanisms underlying emotional affect and dysregulation in psychiatric diseases, with a focus on alcohol use and mood disorders. Her research bridges neuroscience and pharmacology, targeting neural circuits and peptide-based interventions to address negative affective disturbances during abstinence. PhD in Neuroscience (University of North Carolina at Chapel Hill, 2017) Postdoctoral training in transgenic mouse models (Vanderbilt University) Her work combines rodent operant behavior, in vivo/ex vivo techniques, and pharmacological interventions to study: Alcohol-induced interoceptive effects Stress-anxiety interactions Sex-specific neural differences Neurocircuitry in abstinence Recent publications highlight her focus on parabrachial-amygdala circuits, metabotropic glutamate receptors, and peptide targets like PACAP and CGRP. Her research explores how stress hormones, receptor plasticity, and neural pathways contribute to alcohol addiction and anxiety disorders. The Jaramillo Lab, supported by NIAAA R00 funding, aims to develop novel diagnostic tools and treatments for neuropsychiatric conditions through rigorous neuropharmacological and behavioral studies.

Mingrui ZhaoView profile

Associate Professor

• Neuroscience
• Neurodegenerative Diseases
• Epilepsy
• +5 more

Mingrui Zhao is an Associate Professor of Research in Neuroscience at the Brain and Mind Research Institute , Weill Cornell Medical College , with a focus on neurovascular coupling, epilepsy, and neurodegenerative diseases. Their work integrates advanced imaging techniques and genetic models to study seizure mechanisms and tau pathology. Education : M.S. from Beijing University of Chinese Medicine (1996), Ph.D. from Chinese Academy of Medical Sciences (1999), B.M. from Hebei Medical University (1993) Research Interests include neurovascular coupling dynamics during seizures, optogenetic tools for epilepsy network analysis, and molecular pathways in tauopathy. Their studies use animal models and human iPSC-based systems to uncover therapeutic targets. Recent Articles highlight work on APOE3 mutations in tau resilience, laser-based seizure control, and neurovascular uncoupling mechanisms. Publications span journals like Immunity , Cell , and Nature Neuroscience . Primary Email : miz2003@med.cornell.edu

Kelly BijankiView profile

Associate Professor

• Neuromodulation
• Cognitive Neuroscience
• Neuroimaging
• +3 more

Kelly Bijanki, Ph.D. , is an Associate Professor at Baylor College of Medicine with primary affiliation in Neurosurgery and joint appointments in Psychiatry and Neuroscience. Her research focuses on intracranial mapping of affective neural circuits and developing neuromodulation therapies for psychiatric disorders. Baylor College of Medicine (2016-present) Director of Intracranial Monitoring Research Research Platforms: Stereotactic EEG-informed DBS, Human Electrophysiology Research Expertise : Investigates neural substrates of mood disorders using invasive brain recordings Specializes in cingulum bundle, amygdala, and salience network stimulation Develops translational models for affective dysfunction treatment Integrates advanced neuroimaging with electrophysiological data Studies autonomic and facial motor correlates of emotional states Publication Trends : Focus on socio-affective processing networks Emphasizes brain stimulation for psychiatric conditions Combines imaging and electrophysiology in depression research Explores temporal dynamics of neural circuits Develops novel analytical methods for neurostimulation data Scientific Recognition : NIH R01 MH127006 (2021-2026) - $3.6M NIH K01 MH116364 - NIMH Mentored Career Development NIH R21 NS104953 - Exploratory Brain Stimulation Research Caroline Wiess Law Fund Support Collaborative grants with institutions like Duke, UCLA, and University of Iowa Collaborative Network : Key collaborators: Dr. Sarah Heilbronner, Dr. Nader Pouratian, Dr. Nanthia Suthana Multi-institutional partnerships in biophysics and biomedical engineering Leadership in stereotactic EEG-augmented DBS for psychiatric disorders

Christine DeLorenzoView profile

Associate Professor

• Biomarkers of Major Depressive Disorder
• Antidepressant Treatment Response Prediction
• Multimodal Brain Imaging
• +3 more

Christine DeLorenzo serves as Associate Professor of Psychiatry and Biomedical Engineering at Stony Brook University's Renaissance School of Medicine, where she directs neuroimaging research focused on biomarker discovery for Major Depressive Disorder. Her work bridges clinical psychiatry and engineering through multimodal brain imaging techniques and novel PET radioligand development. Her academic training includes: BA in Engineering Sciences from Dartmouth College (1999) MS in Engineering from Thayer School of Engineering, Dartmouth College (2002) PhD in Biomedical Engineering from Yale University (2007) Research Fellowship in Neuroscience at Columbia University (2011) Dr. DeLorenzo's research centers on predicting antidepressant treatment response through multimodal neuroimaging biomarkers , with particular expertise in PET radioligand development and glymphatic system assessment. Her laboratory investigates how obesity, sleep disturbances, and childhood trauma modulate brain structure and function in depression, utilizing advanced techniques like dynamic 18F-FDG PET for cerebrospinal fluid clearance quantification. Recent work explores neuroinflammatory mechanisms in post-COVID neurological sequelae using [18F]-FEPPA imaging. Analysis of her 150+ publications reveals three dominant trajectories: 1) Technical innovation in PET quantification and image reconstruction, 2) Depression biomarker validation across structural, metabolic and neurotransmitter systems, and 3) Expansion into age-related neurodegeneration and post-viral neuroinflammation. Her work increasingly integrates machine learning for low-count PET recovery and treatment prediction. As Principal Investigator, Dr. DeLorenzo leads two major NIH-funded projects: Uncovering Biomarkers of Major Depressive Disorders Using Multimodal Imaging and Characterization of a New Metabotropic Glutamate Receptor Subtype 5 PET Ligand . These initiatives support her laboratory's development of quantitative imaging protocols for clinical translation. Her neuroimaging laboratory operates within Stony Brook's PET Center, utilizing simultaneous PET/MRI systems and advanced computational pipelines for kinetic modeling. The team collaborates with biomedical engineers on AI-driven image reconstruction and with psychiatrists on clinical validation of imaging biomarkers, maintaining active partnerships with Columbia University and Yale.

Cal AdlerView profile

Professor

• Psychiatry
• Neuroimaging
• Bipolar Disorder
• +2 more

Cal Adler is a Professor of Psychiatry and Neuroscience at the University of Cincinnati College of Medicine. He serves as Vice Chair of Clinical Research and Director of the Center for Imaging Research. His work focuses on neuroimaging techniques to investigate healthy cognitive processes and the neuropathophysiology of bipolar and psychotic disorders, with a particular emphasis on psychopharmacologic treatments. B.S., Pennsylvania State University M.D., Thomas Jefferson University Psychiatry Residency, Georgetown University Medical Center Experimental Therapeutics Fellowship, National Institute of Mental Health Research Interests: Dr. Adler specializes in neuroimaging studies of bipolar disorder, including longitudinal analyses of brain structure/function, medication response mechanisms, and risk prediction models for youth offspring of bipolar parents. His work bridges psychiatric neurobiology with advanced imaging modalities like fMRI, MRS, and DTI. Publication Trends: His articles (2015-2021) focus on Neurochemical alterations in bipolar disorder Predictive modeling of treatment response Brain connectivity in mood episodes Lithium and antipsychotic effects Cortical thickness and white matter integrity AI applications in neurotrauma outcomes Scientific Awards: None explicitly listed in the text. Grants: Major funding includes NIH grants (K23, R01, ARRA supplements) for studies on neuroimaging markers of bipolar treatment response, glutamatergic neurotransmission, and multimodal imaging in adolescent mania. He has also received private foundation support from the National Alliance for Research on Schizophrenia and Affective Disorders.

• Neuroendocrinology
• Neuronal Migration
• GnRH Neuron Development
• +4 more

Dr. Susan Wray is a Senior Investigator at the National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH). She leads the Cellular and Developmental Neurobiology Section and holds leadership roles in the International Society of Neuroendocrinology (Council Member) and American Neuroendocrine Society (Founding Member). Her career spans over three decades at NIH, beginning as a postdoctoral fellow at NICHD in 1992 before establishing her independent research group. Research Focus: Dr. Wray's laboratory investigates fundamental mechanisms in neuroendocrine development, with emphasis on: Migration and differentiation of gonadotropin-releasing hormone (GnRH) neurons Craniofacial development and olfactory axon guidance Intracellular signaling controlling neuroendocrine cell motility Regulation of pulsatile GnRH secretion in reproductive states Her recent publications (2020-2023) demonstrate strong focus on genetic determinants of pubertal disorders (e.g., POU6F2, PLXNB1 mutations), neurotransmitter regulation of GnRH neurons (dopamine, acetylcholine), cytoskeletal dynamics in migrating neurons, and novel signaling pathways like nitric oxide-PIP2 interactions. These studies consistently bridge molecular mechanisms with reproductive pathophysiology. Trainees and Lab: Dr. Wray actively mentors early-career researchers including postdoctoral scientists, graduate students, and postbaccalaureate fellows. Her Cellular and Developmental Neurobiology Section employs multidisciplinary approaches from electrophysiology to single-cell genomics.

Heather E. WebberView profile

Assistant Professor

• Psychophysiology
• Reward Functioning
• Addiction Neuroscience
• +5 more

Dr. Heather E. Webber is an Assistant Professor at the Center for Neurobehavioral Research on Addiction (CNRA) within the Faillace Department of Psychiatry and Behavioral Sciences at McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth Houston). She earned her doctorate in psychology with a concentration in cognitive neuroscience from the University of South Florida in 2017 and joined UTHealth Houston initially as a postdoctoral research fellow, where she received the Dean's Award for Excellence in Postdoctoral Research. Dr. Webber's research focuses on the neural mechanisms of motivation, reward sensitivity, emotional functioning, trauma, and sleep as they relate to addiction. She employs human electrophysiological methods , particularly event-related potentials (ERPs), to investigate how these processes contribute to substance use disorders. Her current NIH-funded work aims to identify ERP targets for brain stimulation to develop new treatments for cocaine and other substance use disorders. Her publication record demonstrates significant contributions to the field, with over 25 peer-reviewed articles focusing on electrophysiological biomarkers in addiction, reward processing, and the neural mechanisms underlying substance use disorders. Her work frequently employs meta-analytic approaches to synthesize findings across studies. Scientific Recognition: Dean's Award for Excellence in Postdoctoral Research Award NIDA K01 Award recipient for research on event-related potential targets for brain stimulation Active research program with significant NIH funding As an early-career faculty member, Dr. Webber is enthusiastic about training the next generation of scientists and has mentored several visiting undergraduate and medical students. Her research program bridges basic cognitive neuroscience with clinical applications, aiming to translate neurophysiological findings into novel treatment approaches for substance use disorders. The Center for Neurobehavioral Research on Addiction provides a collaborative environment for her work, connecting basic science with clinical treatment development.

• Neurosciences
• Parkinson's Disease
• Autism Spectrum Disorders
• +5 more

Dr. Anders Borgkvist is a Principal Researcher at the Department of Neuroscience, Karolinska Institutet, where he leads the Anders Borgkvist group . His research focuses on molecular and circuit-level mechanisms in neurodevelopmental and neurodegenerative disorders, with emphasis on dopamine signaling, synaptic plasticity, and basal ganglia pathophysiology. Research Interests: Dr. Borgkvist's work spans Parkinson's disease, autism spectrum disorders, and neuropharmacology. Key areas include: Dopamine-serotonin/acetylcholine cotransmission in striatonigral pathways Synaptic filtering and plasticity in motor sensitization mTOR/autophagy dysregulation in neurodevelopment KCC2-mediated GABAergic inhibition in Parkinsonian motor deficits Grants: Swedish Research Council (2025–2028): Targeting dysregulated basal ganglia output in Parkinson’s disease (investigating KCC2 enhancement as therapy). Swedish Research Council (2017–2020): Synaptic plasticity at dopamine synapses in motor cortex during motor learning . Swedish Research Council (2009–2011): Optical studies on synaptic mechanisms of learning and addiction . His lab utilizes cutting-edge techniques including in vivo fiber photometry, GCaMP imaging, and transgenic models to dissect neural circuit dysfunctions. Collaborations include international experts in neurochemistry and movement disorders.